Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma
ON Pyaskovskaya, IV Boychuk… - Experimental …, 2015 - dspace.nbuv.gov.ua
Significant variability of anticancer efficacy of dichloroacetate (DCA) stimulated an active
search for the agents capable to enhance it antitumor action. Therefore, the aim of this work …
search for the agents capable to enhance it antitumor action. Therefore, the aim of this work …
Antineoplastic activity of the thiazolo [5, 4-b] quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation
Thiazolo [5, 4-b] quinolines are compounds structurally related to m-Amsacrine (m-Amsa), a
potent antileukemic drug that intercalates to DNA and inhibits topoisomerase II in vitro …
potent antileukemic drug that intercalates to DNA and inhibits topoisomerase II in vitro …
Acridine a versatile heterocyclic moiety as anticancer agent
Acridine is a heterocyclic nucleus consisting of three fused rings heterocyclic moiety and a
presence of Nitrogen in the ring structure. It is used in a large number of therapeutically …
presence of Nitrogen in the ring structure. It is used in a large number of therapeutically …
Multisubstituted 1-hydroxy-9-acridones with anticancer activity
TL Su, KA Watanabe - US Patent 5,296,602, 1994 - Google Patents
BACKGROUND OF THE INVENTION Throughout this application, various publications are
referenced. The disclosures of these publications in their entirety are hereby incorporated by …
referenced. The disclosures of these publications in their entirety are hereby incorporated by …
Anti-cancer properties of dichloroacetate
M Latocha, L Żyrek - Polski Merkuriusz Lekarski: Organ Polskiego …, 2022 - europepmc.org
One of the hallmarks of cancer cells is aerobic glycolysis (the Warburg effect). The effect of
dichloroacetate (DCA) is to switch glucose metabolism (cellular respiration) to a more …
dichloroacetate (DCA) is to switch glucose metabolism (cellular respiration) to a more …
Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino) ethyl] acridine-4-carboxamide (DACA) and its analogues
E Pastwa, E Ciesielska, MK Piestrzeniewicz… - Biochemical …, 1998 - Elsevier
An antitumor drug N-[2-(dimethylamino) ethyl] acridine-4-carboxamide (DACA) and its three
close structural analogs N-[2-(hydroxyethylamino) ethyl] acridine-4-carboxamide (DACAH) …
close structural analogs N-[2-(hydroxyethylamino) ethyl] acridine-4-carboxamide (DACAH) …
Retraction Note: Inhibition effects of acridone on the growth of breast cancer cells in vivo.
YF Xia, HJ Chu, GF Kuang, GJ Jiang… - European Review for …, 2024 - europepmc.org
The article" Inhibition effects of acridone on the growth of breast cancer cells in vivo", by Y.-F.
Xia, H.-J. Chu, G.-F. Kuang, G.-J. Jiang, Y.-C. Che, published in Eur Rev Med Pharmacol Sci …
Xia, H.-J. Chu, G.-F. Kuang, G.-J. Jiang, Y.-C. Che, published in Eur Rev Med Pharmacol Sci …
Synthesis and biological activity of new class of dioxygenated anticancer agents
MD Pujol, M Romero, I Sánchez - Current Medicinal Chemistry …, 2005 - ingentaconnect.com
This paper describes extensive research on the activity of more of 100 cytotoxic compounds
containing an oxygenated ring in their structure and isolated from natural plants or prepared …
containing an oxygenated ring in their structure and isolated from natural plants or prepared …
Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancer
E Ryan, AJ Blake, A Benoit, MF David… - Investigational new …, 2013 - Springer
Topoisomerase II (TopoII) plays a critical role in the processes of replication, transcription,
and decantenation in the cell and is an important chemotherapeutic target in the treatment of …
and decantenation in the cell and is an important chemotherapeutic target in the treatment of …
Pre-clinical pharmacokinetics of the acridine antitumour candidate AC04 and its 1-oxo-metabolite plasma profile
MC Pigatto, FDT Uchôa, B Torres, S Haas… - Xenobiotica, 2012 - Taylor & Francis
This work aimed to investigate plasma pharmacokinetics and tissue distribution of a new
acridine derivative 5-acridin-9-ylmethylene-3-(4-methyl-benzyl)-thiazolidine-2, 4-dione …
acridine derivative 5-acridin-9-ylmethylene-3-(4-methyl-benzyl)-thiazolidine-2, 4-dione …